Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welch

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Current Oncology (Toronto, Ont.)|August 17, 2018
Eastern Canadian Colorectal Cancer Consensus Conference 2017S F McGee, W AlGhareeb, C H Ahmad, et al.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
Nature Communications|December 23, 2015
Patterns and functional implications of rare germline variants across 12 cancer typesCharles Lu, Mingchao Xie, Michael C Wendl, et al.
Blood Advances|February 17, 2023
A global study for acute myeloid leukemia with RARG rearrangementHong-Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, et al.
Cell|July 24, 2012
The origin and evolution of mutations in acute myeloid leukemiaJohn S Welch, Timothy J Ley, Daniel C Link, et al.
Nature|March 3, 2016
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysTravis K Warren, Robert Jordan, Michael K Lo, et al.
Archives of Environmental & Occupational Health|May 24, 2013
Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be bannedGuadalupe Aguilar Madrid, Micheline Beaudry, Warren Bell, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Current Oncology (Toronto, Ont.)|August 17, 2018
Eastern Canadian Colorectal Cancer Consensus Conference 2017S F McGee, W AlGhareeb, C H Ahmad, et al.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
Nature Communications|December 23, 2015
Patterns and functional implications of rare germline variants across 12 cancer typesCharles Lu, Mingchao Xie, Michael C Wendl, et al.
Blood Advances|February 17, 2023
A global study for acute myeloid leukemia with RARG rearrangementHong-Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, et al.
Cell|July 24, 2012
The origin and evolution of mutations in acute myeloid leukemiaJohn S Welch, Timothy J Ley, Daniel C Link, et al.
Nature|March 3, 2016
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysTravis K Warren, Robert Jordan, Michael K Lo, et al.
Archives of Environmental & Occupational Health|May 24, 2013
Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be bannedGuadalupe Aguilar Madrid, Micheline Beaudry, Warren Bell, et al.
Pageof 43